BLUF is in public beta. Automated sourcing and summaries by the BLUF engine, monitored by our team. Summaries may contain errors — verify important details at the source. Not medical, legal or financial advice. Public beta — automated summaries may contain errors. Full disclaimer
BLUFSOURCED EVENT BRIEFLAST CHANGED Nov 9, 2026, 7:01 PM
DRUGS, DEVICES & RECALLS • UNITED STATES
Eugia recalls one lot of injectable vancomycin over particulate matter
1 SOURCES UNITED STATESNEW
NOT MEDICAL ADVICE
This brief summarizes public reporting and official announcements. Research findings may be preliminary. Talk to a qualified clinician before making health decisions.
BLUF
Eugia US LLC is voluntarily recalling lot 3VM26026A of vancomycin hydrochloride for injection because particulate matter was found in the product. The recall applies nationwide at the hospital, health care facility and user level.
HOW THIS BRIEF WAS MADE 1 outlet: 1 official. Automated sourcing and summaries by the BLUF engine. Corrections
Why it matters
The recall may affect U.S. hospitals and other health care facilities that use this injectable antibiotic. The supplied notice does not say how many vials are affected or whether anyone has been harmed.
What happens next
The recall notice identifies the affected lot and says the recall is directed to hospitals, health care facilities and users. Further details, including instructions for affected facilities, are not available in the supplied article.
Whether the FDA or Eugia provides additional recall instructions
Whether reports emerge of harm linked to the affected lot